McDonald 2010 MS status at baseline did not apparently affect time to CDMS in patients treated with placebo, as McDonald 2010 MS status in the post hoc analysis was not a significant covariate in the qw versus placebo model, and was of only borderline significance in the tiw versus placebo model.
← all excerpts
Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study.
1
—
—